Three years after Chris Hemsworth shared he had a gene that elevates his likelihood of developing Alzheimer’s, he detailed ...

Three years after Chris Hemsworth shared he had a gene that elevates his likelihood of developing Alzheimer’s, he detailed ...

News about Alzheimer's rose to the forefront in 2025, as the FDA approved the first diagnostic blood test and drugmakers ...

The long-awaited Canadian approval of lecanemab has shifted physicians’ approach to Alzheimer’s disease, addressing previous ...

In two studies, semaglutide failed to slow decline in thousands of people with early stages of Alzheimer's disease.

The actor’s National Geographic documentary shows the power of memory and social connection in supporting his father’s ...

Millions of people are living with Alzheimer's disease, a progressive, irreversible brain disorder that causes cognitive decline, confusion, memory loss, and many other symptoms. The Alzheimer's Assoc ...

Data from the Evoke trials suggests that GLP-1 drugs that treat type 2 diabetes do not have a significant effect on Alzheimer ...

High levels of lead in blood are linked to increased risk for Alzheimer’s disease in older adults, but regular physical activity may reduce the risk, new research shows.

An oral version of semaglutide, the active ingredient in blockbuster drugs Ozempic and Wegovy, failed to slow the progression ...

Rutgers neuroscientist Peng Jiang and his neuroscience colleague Mengmeng Jin have made a discovery they say could reshape ...

When you’re helping an aging parent manage doctors’ appointments, medications, or even the activities of daily life, you don’t need any reminders about the struggles of Alzheimer’s disease. You’re ...